Mon, Dec 29, 2014, 12:07 AM EST - U.S. Markets open in 9 hrs 23 mins


% | $
Quotes you view appear here for quick access.

Solazyme, Inc. Message Board

longbiosilver 5 posts  |  Last Activity: Nov 3, 2014 7:26 AM Member since: Feb 29, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Has anyone been to the Solazyme Careers page lately?

    There are currently about 9 roles in Business Development, Sales & Marketing, like this one:

    Sr. Sales Manager – Industrial Oils, Europe
    This role requires a large degree of independence and strong ability to influence. Candidates ideally should have experience closing commercial contracts with annual value in excess of $3MM and will be comfortable developing and managing a high growth sales territory with $20MM revenue potential.

    The Sr. Sales Manager will execute on, in close cooperation with the Industrial Oils cross functional team, the tactical sales plan for the launch of various Solazyme products. Solazyme is a fast-paced small company environment with multiple, competing priorities. A result driven, action oriented and detailed person who is good at relationship building and persuasion will thrive in this environment.

    Shows confidence. Solazyme needs to keep filling these roles and selling.

    They have the product, now comes the expansion. I'm believe that the call on Wednesday will be a good one.

  • longbiosilver longbiosilver Oct 14, 2014 12:12 AM Flag

    Most analysts on the Street expect Solazyme to reduce its losess substantially in 2015 and post a negative yearly EPS of $0.61, compared to $1.71 that they expect it to post for this year.

    Steve Cohen’s family office, Point72 Asset Management, is also a major shareholder of SZYM, which as of June 30, 2014 owns over 1.38 million shares. Chuck Royce’s Royce & Associates is bullish on the stock, during the second quarter it increased its stake in the company by 76% to 617,000 shares.

  • longbiosilver longbiosilver Oct 13, 2014 11:58 PM Flag

    For John Burbank’s Passport Capital LLC, shorting individual stocks has just become too hard.
    The $3.9 billion hedge-fund firm, which rose 220 percent in 2007 by wagering on a bust in subprime mortgages, reached the conclusion after losing money in June on some of its bets, it said in a second-quarter letter to clients, a copy of which was obtained by Bloomberg News.

    “There is no shame in acknowledging that this is an especially difficult market to make money on shorts even if you feel you have strong skill,” the San Francisco-based firm wrote.

    For Passport, a contrarian investor, the answer isn’t giving up on betting against market declines. Instead, it expects to make fewer concentrated short bets, focusing on easy to trade securities and put options. Short sellers borrow shares to bet on a decline; put options represent the right to sell a set amount of stock at a set price in the future, offering another way to make a bearish bet.

    Passport cited a Goldman Sachs Group Inc. basket of the most wagered-against stocks rising 8.1 percent in June and the bank’s index of companies with weak balance sheets climbing 14 percent this year, the best-performing group.

    “I’m very bullish about U.S. companies, many different sectors, but I’m very bearish about liquidity,” Burbank said in the TV interview. “It’s a strange environment.”

    In my view one of the main reasons SZYM has been shorted so drastically in the past year is to free up shares for the institutional clients. As short sellers have piled into this stock, SZYM's price has dropped. At the same time these events have occurred the percentage of institutional ownership has increased and retail ownership has decreased. They are stealing your shares.

  • John Burbank’s Passport Capital is going even bigger on Solazyme Inc (NASDAQ:SZYM). As a recent filing with Securities and Exchange Commission shows, the fund bought an additional over 1.65 million shares to bring its total holdings in the stock to over 8.08 million shares.By the end of second quarter of this year, Solazyme Inc (NASDAQ:SZYM) was the second largest equity holding of Passport Capital with over 6.4 million shares.

2.68-0.02(-0.74%)Dec 26 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.